Clarix Imaging

Clarix Imaging is a private company funded by the NIH and venture capital, founded by world-renowned medical imaging scientists from the University of Chicago (UC). The company's mission is to provide clinicians with clear tumor visualization and intelligent analysis for precision and personalized medicine. Clarix Imaging's first flagship product is the FDA-approved Volume Specimen Imager (VSI-360), which offers unprecedented clarity in intraoperative specimen margin visualization during breast cancer surgeries, such as lumpectomies. It places true 3D specimen imaging capabilities in real-time at the fingertips of surgeons and radiologists. Unmatched in its precision and workflow-oriented software, the VSI-360 generates an accurate 3D representation of the specimen and allows users to visualize tumors in thin image slices without tissue overlap obscuring the margins.